James Nam, PharmD

Most Recent Articles by James Nam, PharmD

PD-1/PD-L1 Inhibitors May Increase the Risk of Hyperprogressive Disease in NSCLC

PD-1/PD-L1 Inhibitors May Increase the Risk of Hyperprogressive Disease in NSCLC

By

The association between disease progression and PD-1/PD-L1 inhibitors in non-small cell lung cancer is unknown.

S-1 Plus Carboplatin May Be Effective in NSCLC Patients With Interstitial Lung Disease

S-1 Plus Carboplatin May Be Effective in NSCLC Patients With Interstitial Lung Disease

By

Patients with severe complications, such as interstitial lung disease, are often excluded from clinical studies assessing chemotherapy in NSCLC.

High-Dose Busulfan Plus Melphalan Consolidation Therapy May Improve Outcomes in Ewing Sarcoma

High-Dose Busulfan Plus Melphalan Consolidation Therapy May Improve Outcomes in Ewing Sarcoma

By

Previous studies have suggested that high-dose therapy with busulfan plus melphalan may confer a benefit to patients with Ewing sarcoma compared with conventional chemotherapy.

Elotuzumab May Improve Outcomes Without Negatively Impacting HRQoL in Multiple Myeloma

Elotuzumab May Improve Outcomes Without Negatively Impacting HRQoL in Multiple Myeloma

By

Previous studies showed that elotuzumab plus lenalidomide and dexamethasone improved progression-free survival and response rates, but its impact on patient-reported outcomes is unknown.

Neoadjuvant Chemotherapy Before Radical Cystectomy May Improve Outcomes in Bladder Cancer

Neoadjuvant Chemotherapy Before Radical Cystectomy May Improve Outcomes in Bladder Cancer

By

Researchers assess the outcomes of 5517 patients with bladder cancer who underwent radical cystectomy with or without neoadjuvant radiotherapy or chemotherapy.

More Articles by James Nam, PharmD

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs